| scholarly article | Q13442814 |
| P50 | author | Danni Deng | Q85727572 |
| P2093 | author name string | Rong Wang | |
| Yi Zhang | |||
| Qiang Wang | |||
| Qing Lan | |||
| Feng Zhi | |||
| Yilin Yang | |||
| Lian Xue | |||
| Naiyuan Shao | |||
| Suinuan Wang | |||
| Xiwei Xia | |||
| Yimin Shi | |||
| P2860 | cites work | The 2007 WHO classification of tumours of the central nervous system | Q24685772 |
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | Q28131780 | ||
| MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3 | Q28564217 | ||
| Malignant gliomas in adults | Q29615708 | ||
| GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis | Q31035468 | ||
| Expression Profile of MicroRNAs in Serum: A Fingerprint for Esophageal Squamous Cell Carcinoma | Q34143366 | ||
| Genetic variation in microRNA networks: the implications for cancer research | Q34177121 | ||
| Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer | Q34202973 | ||
| Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas | Q34279430 | ||
| Circulating miRNAs as new blood-based biomarkers for solid cancers | Q34331651 | ||
| Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia | Q34599349 | ||
| miR-106a-5p inhibits the proliferation and migration of astrocytoma cells and promotes apoptosis by targeting FASTK | Q34980918 | ||
| Identification and functional characterization of microRNAs involved in the malignant progression of gliomas | Q35004717 | ||
| Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma | Q36560956 | ||
| Identification of serum microRNA profiles in colon cancer | Q36889636 | ||
| MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas | Q36915053 | ||
| MicroRNAs and cancer: profile, profile, profile | Q37039839 | ||
| Circulating microRNAs predict biochemical recurrence in prostate cancer patients | Q37081843 | ||
| Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer | Q37140258 | ||
| Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers | Q37989885 | ||
| miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1. | Q39156112 | ||
| MiR-16-1 plays a role in reducing migration and invasion of glioma cells. | Q39240322 | ||
| MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status. | Q39528026 | ||
| MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells | Q39896800 | ||
| MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells | Q41161526 | ||
| Identification of circulating microRNA signatures for breast cancer detection | Q43511958 | ||
| A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma | Q44460060 | ||
| Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma | Q44500035 | ||
| A specific miRNA signature in the peripheral blood of glioblastoma patients | Q45256953 | ||
| The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma | Q48277168 | ||
| Blood alterations preceding clinical manifestation of glioblastoma | Q48338469 | ||
| Plasma MicroRNA-21 concentration may be a useful biomarker in glioblastoma patients | Q48409555 | ||
| A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis | Q54399995 | ||
| P433 | issue | 3 | |
| P921 | main subject | microRNA | Q310899 |
| biomarker | Q864574 | ||
| P304 | page(s) | 383-391 | |
| P577 | publication date | 2014-08-18 | |
| P1433 | published in | Neuro-Oncology | Q15724471 |
| P1476 | title | Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma | |
| P478 | volume | 17 |
| Q50000797 | A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker |
| Q47998452 | A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker. |
| Q37202515 | A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma |
| Q47136432 | A three-microRNA signature for lung squamous cell carcinoma diagnosis in Chinese male patients |
| Q91752709 | Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma |
| Q38795672 | Carbon nanotubes: a novel material for multifaceted applications in human healthcare. |
| Q91012634 | Circulating biomarkers in patients with glioblastoma |
| Q36245788 | Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma |
| Q41050204 | Circulating microRNAs as emerging non-invasive biomarkers for gliomas |
| Q91834787 | Diagnostic and Prognostic Potential of Serum Cell-Free microRNA-214 in Glioma |
| Q35710429 | Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis. |
| Q49461890 | Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer |
| Q92550255 | Inhibition of miR-19a protects neurons against ischemic stroke through modulating glucose metabolism and neuronal apoptosis |
| Q36262967 | Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer |
| Q38813857 | MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations |
| Q37154118 | MiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B gene |
| Q38590626 | MicroRNA as potential biomarkers in Glioblastoma |
| Q64899756 | MicroRNA based theranostics for brain cancer: basic principles. |
| Q37117127 | MicroRNA-20a-5p contributes to hepatic glycogen synthesis through targeting p63 to regulate p53 and PTEN expression |
| Q92642131 | Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies |
| Q38621047 | Pilot Study of Whole Blood MicroRNAs as Potential Tools for Diffuse Low-Grade Gliomas Detection |
| Q42317085 | Serum microRNA profiling in patients with glioblastoma: a survival analysis |
| Q91599145 | The Role of Circulating MicroRNA in Glioblastoma Liquid Biopsy |
| Q89018078 | The Utility of Liquid Biopsy in Central Nervous System Malignancies |
| Q58802654 | The emerging role of miR-19 in glioma |
| Q39126705 | The miR-17-92 cluster as a potential biomarker for the early diagnosis of gastric cancer: evidence and literature review |
| Q42207693 | miR‑181b‑5p mediates TGF‑β1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells |
| Q55456731 | microRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis. |
Search more.